
David Larsen
Stock Analyst at BTIG
(0.27)
# 4,661
Out of 5,162 analysts
600
Total ratings
37.7%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintained: Hold | n/a | $22.94 | - | 14 | Nov 10, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | n/a | $1.12 | - | 11 | Nov 10, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $340 → $360 | $306.40 | +17.49% | 15 | Nov 9, 2026 | |
| DOCS Doximity | Reiterated: Hold | n/a | $32.87 | - | 13 | Nov 8, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | n/a | $1.51 | - | 27 | Nov 8, 2026 | |
| STLN Starling Oncology | Maintained: Buy | $9 → $10 | $4.00 | +150.00% | 13 | Nov 6, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $8 | $4.71 | +69.85% | 52 | Nov 5, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $18 → $20 | $14.60 | +36.99% | 9 | Nov 5, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $35 | $15.09 | +131.94% | 4 | Nov 5, 2026 | |
| AMWL American Well | Reiterated: Hold | n/a | $12.46 | - | 27 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $88.41 | +24.42% | 17 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $37.35 | - | 27 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.98 | - | 21 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.06 | +191.26% | 1 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $278.84 | - | 12 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $26 | $20.47 | +27.02% | 34 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2518 | - | 20 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $102.11 | +12.62% | 32 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $40.71 | +35.10% | 8 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $42.87 | +16.63% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $33.77 | +92.48% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $24.54 | +42.62% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $9 | $2.10 | +329.59% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $69.15 | +30.15% | 19 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $40 | $35.95 | +11.27% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.25 | n/a | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $114.02 | n/a | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $345.76 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $353.34 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $85.25 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $274.29 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $9 | $0.184 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $1,059.37 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $4.75 | n/a | 8 | Jun 19, 2017 |
Hims & Hers Health
Nov 10, 2026
Maintained: Hold
Price Target: n/a
Current: $22.94
Upside: -
Definitive Healthcare
Nov 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.12
Upside: -
Veeva Systems
Nov 9, 2026
Reiterated: Buy
Price Target: $340 → $360
Current: $306.40
Upside: +17.49%
Doximity
Nov 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.87
Upside: -
Health Catalyst
Nov 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.51
Upside: -
Starling Oncology
Nov 6, 2026
Maintained: Buy
Price Target: $9 → $10
Current: $4.00
Upside: +150.00%
Evolent Health
Nov 5, 2026
Reiterated: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
LifeStance Health Group
Nov 5, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $14.60
Upside: +36.99%
Omada Health
Nov 5, 2026
Reiterated: Buy
Price Target: $35
Current: $15.09
Upside: +131.94%
American Well
Nov 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.46
Upside: -
Nov 3, 2026
Reiterated: Buy
Price Target: $110
Current: $88.41
Upside: +24.42%
Nov 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $37.35
Upside: -
Oct 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.98
Upside: -
Oct 27, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.06
Upside: +191.26%
Oct 27, 2026
Rated: Hold
Price Target: n/a
Current: $278.84
Upside: -
Oct 13, 2026
Reiterated: Buy
Price Target: $25 → $26
Current: $20.47
Upside: +27.02%
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.2518
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: $115
Current: $102.11
Upside: +12.62%
Aug 27, 2026
Reiterated: Buy
Price Target: $55
Current: $40.71
Upside: +35.10%
Aug 10, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $42.87
Upside: +16.63%
Aug 9, 2026
Reiterated: Buy
Price Target: $65
Current: $33.77
Upside: +92.48%
Aug 9, 2026
Reiterated: Buy
Price Target: $35
Current: $24.54
Upside: +42.62%
Aug 6, 2026
Rated: Buy
Price Target: $10 → $9
Current: $2.10
Upside: +329.59%
Aug 3, 2026
Reiterated: Buy
Price Target: $90
Current: $69.15
Upside: +30.15%
Jul 24, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $35.95
Upside: +11.27%
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $4.25
Upside: n/a
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $114.02
Upside: n/a
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $345.76
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $353.34
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $85.25
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $274.29
Upside: n/a
Oct 31, 2018
Reiterated: Hold
Price Target: $17 → $9
Current: $0.184
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $1,059.37
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $4.75
Upside: n/a